Transvenous hemodynamic assessment of experimental arteriovenous malformations. Doppler guidewire monitoring of embolotherapy in a swine model.
Transvenous hemodynamic assessment of experimental arteriovenous malformations. Doppler guidewire monitoring of embolotherapy in a swine model.
复制标题
实验性动静脉畸形的经静脉血流动力学评估。
DOI:
10.1161/01.str.27.8.1365
复制
发表时间:
1996
期刊:
影响因子:
8.3
通讯作者:
Viñuela,F
中科院分区:
文献类型:
--
作者:
Murayama,Y;Massoud,TF;Viñuela,F
Background and PurposeA Doppler guidewire was used to monitor progressive changes in draining vein flow parameters during experimental embolotherapy in a swine arteriovenous malformation (AVM) model.MethodsA microcatheter was positioned superselectively in the main arterial feeder and main draining vein in each of 10 AVM models in swine. With use of the Doppler guidewire, preembolization arterial and venous average peak velocities (APVs) and pulsatility indices were recorded. The device was left in the draining vein during transarterial particulate (in 8 swine) or liquid adhesive (in 2 swine) embolization, and continuous transvenous flow during and after treatment was monitored. Periembolization Doppler flow parameters were correlated qualitatively with angiographic changes in the nidus.ResultsPreembolization draining vein flow was pulsatile, with a mean APV of 38.9±13.7 cm/s. After embolization, this changed significantly to a less pulsatile or nonpulsatile pattern, with a lower mean APV of 9.2±4.9 cm/s (P=.0001). A novel expression, the maximum minus the minimum peak velocity (MxPV−MnPV), was used in evaluating the transvenous Doppler spectra. This was reduced significantly after embolization from a mean of 11.1±3.5 cm/s to 6.7±2.5 cm/s (P=.0025). Objective periembolization hemodynamic changes were detected in the draining veins earlier than the visually subjective angiographic changes within the nidus.ConclusionsTransvenous Doppler guidewire assessment of two parameters, APV and MxPV−MnPV, is useful in the hemodynamic evaluation of experimental arteriovenous shunting and may be used for future objective and quantitative monitoring during endovascular AVM embolotherapy.